ROCKWELL MEDICAL, INC. Amortization of Debt Issuance Costs
ROCKWELL MEDICAL, INC. (RMTI) reported Amortization of Debt Issuance Costs of $882.72 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2017-03-15
- ROCKWELL MEDICAL, INC. amortization of debt issuance costs for the quarter ending 2014-12-31 was $525.58K.
- ROCKWELL MEDICAL, INC. amortization of debt issuance costs for the quarter ending 2014-09-30 was $130.08K.
- ROCKWELL MEDICAL, INC. amortization of debt issuance costs for the quarter ending 2014-06-30 was $113.53K.
- ROCKWELL MEDICAL, INC. amortization of debt issuance costs for the quarter ending 2014-03-31 was $113.53K.
- ROCKWELL MEDICAL, INC. amortization of debt issuance costs for fiscal 2014 was $882.72K, a 288.76% increase from fiscal 2013.
- ROCKWELL MEDICAL, INC. amortization of debt issuance costs for fiscal 2013 was $227.06K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2014-12-31 | $525.58K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $655.66K derived: sum of 2 quarters · filed 2017-03-15 | $769.19K derived: sum of 3 quarters · filed 2017-03-15 | $882.72K 10-K · filed 2017-03-15 |
| 2014-09-30 | $130.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $243.61K derived: sum of 2 quarters · filed 2015-11-09 | $357.14K 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $113.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $227.06K 10-Q · filed 2015-08-04 | ||
| 2014-03-31 | $113.53K 10-Q · filed 2015-05-07 | |||
| 2013-12-31 | $227.06K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |